
Oxford Nanopore
To enable the analysis of anything, by anyone, anywhere
Guardant Health is an American biotechnology company co-founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz. The company specializes in precision oncology, developing advanced blood-based tests to detect and monitor cancer through non-invasive liquid biopsies rather than traditional tissue biopsies. Their mission is deeply personal and driven by firsthand experiences with cancer, aiming to empower patients and healthcare providers to make informed treatment decisions that improve cancer outcomes.
The company’s portfolio includes developing a blood test for early cancer screening, starting with colorectal cancer, which enables detection from a routine blood draw. Guardant Health focuses on assisting doctors in managing patients across all cancer stages—from identifying recurrence risk after surgery in early-stage cancer to selecting and monitoring treatments for advanced cancer. They are also dedicated to accelerating drug development for the biopharmaceutical industry by providing valuable genomic insights through their testing technologies.
Guardant Health holds numerous patents, including key ones acquired from Swiss biochemist Maurice Stroun, which support their innovative liquid biopsy platform. Their tests have demonstrated high accuracy in detecting genetic mutations associated with tumors, offering a comprehensive, biopsy-free cancer diagnostic option. The company went public in 2018, raising significant capital to expand their impact in precision oncology.
With a commitment to preserving the promise of every human life affected by cancer, Guardant Health continuously develops new products—having launched around 15 innovative solutions to improve cancer care. Their work not only aids in patient treatment but also enhances clinical trials and drug development processes, contributing to the next generation of precision medicines.
Headquartered in Redwood City, California, Guardant Health operates at the intersection of biotechnology and oncology, striving to transform cancer care globally through cutting-edge liquid biopsy technology and a patient-first approach.
Report this companyCompany DescriptionGuardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics….
Company DescriptionGuardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics….
Company DescriptionGuardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics….
Company DescriptionGuardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics….
Some companies operating in Biotechnology industry.
To enable the analysis of anything, by anyone, anywhere
Transforming Cancer Care with AI Precision Medicine
Worldwide Clinical Trials is the cure for the common CRO, providing top-performing clinical development services globally.
Science for a Safer World.
Developing replacement therapies for rare genetic diseases with the goal of delivering meaningful improvements in quality of life.
Engineering a transformative tomorrow
To serve patients.
Committed to developing innovative medicines and partnering with the global community to help as many patients with cancer as possible.
Jobicy
562 subscribers are already enjoying exclusive, experimental and pre-release features.
Free
USD $0/month
For people just getting started
Plus
USD $8/month
Everything in Free, and:
👎 👍
Work at Guardant Health? Share your experiences.